» Articles » PMID: 3930522

Permissive Role of Interleukin 3 (IL-3) in Proliferation and Differentiation of Multipotential Hemopoietic Progenitors in Culture

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 1985 Aug 1
PMID 3930522
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the effects of interleukin-3 (IL-3) on colony formation by hemopoietic progenitors in methylcellulose cultures of spleen cells from 5-fluorouracil (FU)-treated mice. Purified IL-3 supported the growth of various types of multilineage colonies including blast cell colonies. The types of colonies were similar to those supported by pokeweed-mitogen spleen cell conditioned medium (PWM-SCM), except that IL-3 supported eosinophil and neutrophil expression better. Delayed addition of IL-3 to cultures 7 days after cell plating decreased the number of colonies to one-half the number in cultures with IL-3 added on day 0. It did not alter the proliferative and differentiation characteristics of late emerging multipotential blast cell colonies. These observations suggest that IL-3 does not trigger hemopoietic progenitors into active cell proliferation but is necessary for their continued proliferation. This permissive role of IL-3 is consistent with a stochastic model of stem cell proliferation which features random entry into cell cycle. IL-3 also supported the growth of multilineage colonies from single cells isolated from blast cell colonies by micromanipulation. This result shows that IL-3 acts directly on multipotential progenitors. Analysis of colonies derived from paired progenitors revealed disparate lineage expression and was in accordance with the stochastic model of stem cell differentiation.

Citing Articles

IL3-Driven T Cell-Basophil Crosstalk Enhances Antitumor Immunity.

Wei J, Mayberry C, Lv X, Hu F, Khan T, Logan N Cancer Immunol Res. 2024; 12(7):822-839.

PMID: 38739030 PMC: 11219266. DOI: 10.1158/2326-6066.CIR-23-0851.


IL3 Has a Detrimental Effect on Hematopoietic Stem Cell Self-Renewal in Transplantation Settings.

Tajer P, Cante-Barrett K, Naber B, Vloemans S, van Eggermond M, van der Hoorn M Int J Mol Sci. 2022; 23(21).

PMID: 36361533 PMC: 9655151. DOI: 10.3390/ijms232112736.


Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation.

Sezaki M, Hayashi Y, Wang Y, Johansson A, Umemoto T, Takizawa H Front Immunol. 2020; 11:585367.

PMID: 33329562 PMC: 7732516. DOI: 10.3389/fimmu.2020.585367.


Targeted Diphtheria Toxin-Based Therapy: A Review Article.

Shafiee F, Aucoin M, Jahanian-Najafabadi A Front Microbiol. 2019; 10:2340.

PMID: 31681205 PMC: 6813239. DOI: 10.3389/fmicb.2019.02340.


Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies.

Alkharabsheh O, Frankel A Biomedicines. 2019; 7(1).

PMID: 30621282 PMC: 6466259. DOI: 10.3390/biomedicines7010006.